Although the patients all had diabetes and were successfully treated via standard diabetic ketoacidosis protocols, the etiology of these early cases differed significantly from SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis [1]. This evidence concerns the gene SLC5A2 and diabetes mellitus.